scholarly journals OP15.08: Fetal abnormalities leading to 3rdtrimester abortion: 9 year experience from a single Medical Center

2008 ◽  
Vol 32 (3) ◽  
pp. 362-362
Author(s):  
O. Barel ◽  
Z. Vaknin ◽  
N. Smorgick ◽  
O. Reish ◽  
S. Mendelovic ◽  
...  
2006 ◽  
Vol 26 (10) ◽  
pp. 938-943 ◽  
Author(s):  
Zvi Vaknin ◽  
Ido Ben-Ami ◽  
Orit Reish ◽  
Arie Herman ◽  
Ron Maymon

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Hitomi Imafuku ◽  
Hideto Yamada ◽  
Akiko Uchida ◽  
Masashi Deguchi ◽  
Tokuro Shirakawa ◽  
...  

AbstractThis prospective cohort study aimed to determine clinical factors associated with congenital cytomegalovirus (CMV) infection in pregnancy. Newborns born at a perinatal medical center received PCR analyses for CMV-DNA in their urine with informed consent. Clinical data, including age, maternal fever or flu-like symptoms, complications, ultrasound fetal abnormality, gestational weeks at delivery, and birth weight, were collected. Logistic regression analyses determined clinical findings associated with congenital CMV infection (cCMV). cCMV was diagnosed in 32 of 4380 pregnancies. Univariate and multivariable analyses revealed that age < 25 years old (OR 2.7, 95% CI 1.1–6.6; p < 0.05), the presence of maternal fever or flu-like symptoms (5.4, 2.6–11.2; p < 0.01), ultrasound fetal abnormalities (12.7, 5.8–27.7; p < 0.01), and preterm delivery at less than 34 gestational weeks (2.6, 1.1–6.0; p < 0.05) were independent clinical findings associated with cCMV. A combination of maternal fever/flu-like symptoms, ultrasound fetal abnormalities, or preterm delivery at less than 34 gestational weeks as optimal predictive factors showed 90.6% sensitivity, 66.4% specificity, and a maximum Youden index of 0.57. CMV-DNA tests in the urine of newborns born to mothers with these clinical manifestations may be an effective method in detecting cCMV as a targeted screening with a high sensitivity.


2009 ◽  
Vol 29 (3) ◽  
pp. 223-228 ◽  
Author(s):  
Oshri Barel ◽  
Zvi Vaknin ◽  
Noam Smorgick ◽  
Orit Reish ◽  
Sonia Mendlovic ◽  
...  

2016 ◽  
Vol 30 (3) ◽  
pp. 347-351 ◽  
Author(s):  
Yaakov Melcer ◽  
Ran Svirsky ◽  
Zvi Vaknin ◽  
Orna Levinsohn-Tavor ◽  
Noa Feldman ◽  
...  

2017 ◽  
Vol 31 (6) ◽  
pp. 740-746 ◽  
Author(s):  
Noa Feldman ◽  
Yaakov Melcer ◽  
Edward Hod ◽  
Orna Levinsohn-Tavor ◽  
Ran Svirsky ◽  
...  

2009 ◽  
Vol 25 (2) ◽  
pp. 291-296 ◽  
Author(s):  
Zvi Vaknin ◽  
Yael Lahat ◽  
Oshri Barel ◽  
Ido Ben-Ami ◽  
Orit Reish ◽  
...  

1999 ◽  
Vol 27 (2) ◽  
pp. 205-205
Author(s):  
choeffel Amy

The U.S. Court of Appeals for the District of Columbia upheld, in Presbyterian Medical Center of the University of Pennsylvania Health System v. Shalala, 170 F.3d 1146 (D.C. Cir. 1999), a federal district court ruling granting summary judgment to the Department of Health and Human Services (DHHS) in a case in which Presbyterian Medical Center (PMC) challenged Medicare's requirement of contemporaneous documentation of $828,000 in graduate medical education (GME) expenses prior to increasing reimbursement amounts. DHHS Secretary Donna Shalala denied PMC's request for reimbursement for increased GME costs. The appellants then brought suit in federal court challenging the legality of an interpretative rule that requires requested increases in reimbursement to be supported by contemporaneous documentation. PMC also alleged that an error was made in the administrative proceedings to prejudice its claims because Aetna, the hospital's fiscal intermediary, failed to provide the hospital with a written report explaining why it was denied the GME reimbursement.


Sign in / Sign up

Export Citation Format

Share Document